Epoch Investment Partners’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.5M | Sell |
261,497
-89,476
| -25% | -$7M | 0.11% | 182 |
|
|
2025
Q1 | $25.4M | Buy |
350,973
+46,772
| +15% | +$3.39M | 0.13% | 178 |
|
|
2024
Q4 | $22.5M | Sell |
304,201
-29,294
| -9% | -$2.17M | 0.11% | 180 |
|
|
2024
Q3 | $22M | Sell |
333,495
-115,456
| -26% | -$7.62M | 0.1% | 188 |
|
|
2024
Q2 | $41.5M | Buy |
448,951
+914
| +0.2% | +$84.4K | 0.19% | 174 |
|
|
2024
Q1 | $42.8M | Sell |
448,037
-141,033
| -24% | -$13.5M | 0.19% | 182 |
|
|
2023
Q4 | $44.9M | Buy |
589,070
+266,292
| +83% | +$20.3M | 0.2% | 174 |
|
|
2023
Q3 | $22.4M | Sell |
322,778
-9,251
| -3% | -$641K | 0.14% | 189 |
|
|
2023
Q2 | $31.3M | Sell |
332,029
-4,607
| -1% | -$435K | 0.18% | 175 |
|
|
2023
Q1 | $27.8M | Sell |
336,636
-6,941
| -2% | -$574K | 0.17% | 180 |
|
|
2022
Q4 | $25.6M | Buy |
343,577
+257,972
| +301% | +$19.2M | 0.15% | 183 |
|
|
2022
Q3 | $7.07M | Buy |
85,605
+1,962
| +2% | +$162K | 0.05% | 284 |
|
|
2022
Q2 | $7.95M | Buy |
83,643
+2,664
| +3% | +$253K | 0.05% | 281 |
|
|
2022
Q1 | $9.53M | Hold |
80,979
| – | – | 0.05% | 283 |
|
|
2021
Q4 | $10.5M | Sell |
80,979
-14,176
| -15% | -$1.84M | 0.05% | 272 |
|
|
2021
Q3 | $10.8M | Sell |
95,155
-3
| -0% | -$340 | 0.06% | 256 |
|
|
2021
Q2 | $9.86M | Sell |
95,158
-15,343
| -14% | -$1.59M | 0.05% | 258 |
|
|
2021
Q1 | $9.24M | Buy |
110,501
+26,364
| +31% | +$2.21M | 0.04% | 253 |
|
|
2020
Q4 | $7.68M | Buy |
84,137
+4,413
| +6% | +$403K | 0.04% | 252 |
|
|
2020
Q3 | $6.36M | Buy |
+79,724
| New | +$6.36M | 0.03% | 240 |
|